Similar to this, ST6GAL2 silencing reduced the proliferation of MCF-7 and T47D breast cancer cells by stopping cell cycle progression at the G0/G1 phase and decreasing the proportion of cells in the S phase [14]. The gene discussed is ST6GAL2; the disease is breast carcinoma.